MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clml.2026.01.014

Медицинская библиотека · Clinical lymphoma, myeloma & leukemia · 2026

Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients.

Dillard Christen M, Gurumurthi Ashwath, Lee Hans C, Thomas Sheeba K, Weber Donna M, Orlowski Robert Z, Qazilbash Muzaffar H, Patel Krina K, Hildebrandt Michelle A T

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Despite the introduction of novel antimyeloma therapies, Black and Hispanic individuals with multiple myeloma (MM) often experience worse survival outcomes than White counterparts, influenced not only by disease-related factors but by nonbiological factors such as social drivers of health (SDOH). We evaluated the impact of the Area Deprivation Index (ADI), a neighborhood-level SDOH measure, on survival in patients with MM receiving standardized, high-quality care.

METHODS

We conducted a retrospective cohort study of 476 patients with newly diagnosed MM treated at The University of Texas MD Anderson Cancer Center from January 2010 to December 2017. Progression-free survival (PFS) and overall survival (OS) were the primary outcomes.

RESULTS

Of the cohort, 27% self-identified as Black, 18% as Hispanic, and 55% as White; 54% were male. Black and Hispanic patients were younger at diagnosis (median age 58.3 years) compared to White patients (63.1 years). White patients resided in neighborhoods with lower mean ADI values (51.7 ± 23.3) than Black (61.2 ± 21.5) and Hispanic (63.7 ± 19.3) patients, indicating lower deprivation. Higher ADI correlated with more advanced disease stage but no other clinical features. PFS and OS did not differ significantly by ADI quartile or race/ethnicity groups. Survival outcomes remained consistent in both race/ethnicity- and ADI-stratified analyses.

CONCLUSIONS

Although Black and Hispanic patients lived in areas of greater deprivation, survival outcomes were comparable across ADI and racial/ethnic groups. These findings suggest that access to standardized, high-quality care may mitigate disparities in outcomes driven by SDOH. Replication in other care settings is warranted.

Для цитирования: Dillard Christen M, Gurumurthi Ashwath, Lee Hans C, Thomas Sheeba K, Weber Donna M, Orlowski Robert Z, Qazilbash Muzaffar H, Patel Krina K, Hildebrandt Michelle A T. Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients.. Clinical lymphoma, myeloma & leukemia. 2026. DOI: 10.1016/j.clml.2026.01.014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.